Carlos G. Grijalva, MD MPH FIDSA

About Carlos G. Grijalva, MD MPH FIDSA

Carlos G. Grijalva, MD MPH FIDSA, With an exceptional h-index of 73 and a recent h-index of 59 (since 2020), a distinguished researcher at Vanderbilt University, specializes in the field of Pharmacoepidemiology, vaccines, pneumococcal diseases, pneumonia, influenza.

His recent articles reflect a diverse array of research interests and contributions to the field:

Accuracy of Influenza ICD-10 Diagnosis Codes in Identifying Influenza Illness in Children

SARS-CoV-2 shedding and evolution in patients who were immunocompromised during the omicron period: a multicentre, prospective analysis

268 Association between social vulnerability and severe maternal morbidity

124 Prescription opioid exposure and risk of spontaneous preterm delivery

Oseltamivir May or May Not Reduce Hospitalizations

Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults

Durability of protection from original monovalent and bivalent COVID-19 vaccines against COVID-19-associated hospitalization and severe in-hospital outcomes among adults in the …

Influenza virus shedding and symptoms: Dynamics and implications from a multi-season household transmission study

Carlos G. Grijalva, MD MPH FIDSA Information

University

Position

Associate Professor of Preventive Medicine - Health Policy

Citations(all)

26945

Citations(since 2020)

15529

Cited By

16504

hIndex(all)

73

hIndex(since 2020)

59

i10Index(all)

214

i10Index(since 2020)

181

Email

University Profile Page

Google Scholar

Carlos G. Grijalva, MD MPH FIDSA Skills & Research Interests

Pharmacoepidemiology

vaccines

pneumococcal diseases

pneumonia

influenza

Top articles of Carlos G. Grijalva, MD MPH FIDSA

Accuracy of Influenza ICD-10 Diagnosis Codes in Identifying Influenza Illness in Children

JAMA Network Open

2024/4/1

SARS-CoV-2 shedding and evolution in patients who were immunocompromised during the omicron period: a multicentre, prospective analysis

The Lancet Microbe

2024/1/23

268 Association between social vulnerability and severe maternal morbidity

American Journal of Obstetrics & Gynecology

2024/1/1

124 Prescription opioid exposure and risk of spontaneous preterm delivery

American Journal of Obstetrics & Gynecology

2024/1/1

Oseltamivir May or May Not Reduce Hospitalizations

JAMA Internal Medicine

2024/1/1

Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults

JAMA Network Open

2024/4/1

Durability of protection from original monovalent and bivalent COVID-19 vaccines against COVID-19-associated hospitalization and severe in-hospital outcomes among adults in the …

medRxiv

2024

Influenza virus shedding and symptoms: Dynamics and implications from a multi-season household transmission study

medRxiv

2024

P21 A Phase 3 randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability and immunogenicity of a 21-valent PCV, V116, in pneumococcal …

JAC-Antimicrobial Resistance

2024/1

Anti-SARS-CoV-2 Antibody Levels Associated With COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu Vaccine Effectiveness Network, October 2021-June 2022

The Journal of Infectious Diseases

2024/2/23

Impact of respiratory viral infections on nasopharyngeal pneumococcal colonization dynamics in children

2024/6/1

Anti–SARS-CoV-2 Antibody Levels Associated With COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu Vaccine Effectiveness Network, October 2021–June 2022

The Journal of Infectious Diseases

2024/2/23

Removal of Race and White Blood Cell Count in an Updated Pediatric Pneumonia Severity Model

Hospital Pediatrics

2024/2/9

Vaccine effectiveness against influenza A–associated hospitalization, organ failure, and death: United States, 2022–2023

Clinical infectious diseases

2024/4/15

Prescription Opioid Exposure During Pregnancy and Risk of Spontaneous Preterm Delivery

JAMA Network Open

2024/2/5

Protection of messenger RNA vaccines against hospitalized coronavirus disease 2019 in adults over the first year following authorization in the United States

Clinical Infectious Diseases

2023/2/1

Work Attendance with Acute Respiratory Illness Before and During COVID-19 Pandemic, United States, 2018–2022

Emerging Infectious Diseases

2023/12

Changes in medication initiation and selection patterns for gestational diabetes management

Authorea Preprints

2023/5/2

Social vulnerability and initiation of pharmacotherapy for gestational diabetes mellitus in a Medicaid population

Women's Health Issues

2023/5/1

2302. Transmissibility of SARS-CoV-2 by symptom: data from a case-ascertained household transmission study

Open Forum Infectious Diseases

2023/12

See List of Professors in Carlos G. Grijalva, MD MPH FIDSA University(Vanderbilt University)

Co-Authors

academic-engine